[go: up one dir, main page]

AR070999A1 - Soluciones oftalmicas que muestran una eficacia mejorada - Google Patents

Soluciones oftalmicas que muestran una eficacia mejorada

Info

Publication number
AR070999A1
AR070999A1 ARP090100992A ARP090100992A AR070999A1 AR 070999 A1 AR070999 A1 AR 070999A1 AR P090100992 A ARP090100992 A AR P090100992A AR P090100992 A ARP090100992 A AR P090100992A AR 070999 A1 AR070999 A1 AR 070999A1
Authority
AR
Argentina
Prior art keywords
ppm
composition
alkali metal
water soluble
show
Prior art date
Application number
ARP090100992A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR070999A1 publication Critical patent/AR070999A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12—Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124—Hydrogen peroxide; Peroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A61L12/145—Polymeric quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente hace referencia a composiciones oftálmicas que comprenden un pH entre aproximadamente 6 y aproximadamente 8 y entre aproximadamente 50 y aproximadamente 1000 ppm de peroxido de hidrogeno, desde alrededor de 100 ppm hasta alrededor de 2000 ppm de por lo menos un compuesto clorito y desde alrededor de 20 hasta 100 ppm de por lo menos una sal de cuaternio polimérico saturada. Las composiciones oftálmicas muestran una mejorada eficacia antifungica contra fusarium solani. Reivindicacion 9: La composicion de la reivindicacion 5, caracterizada porque dicho agente quelante comprende ácido dietilentriamino pentametilen fosfonico. Reivindicacion 18: La composicion de la reivindicacion 17, caracterizada porque dicho compuesto clorito se selecciona del grupo formado por cloritos de metal álcali solubles en agua, cloritos de metal alcalino solubles en agua y mezclas de los mismos. Reivindicacion 26: La composicion de la reivindicacion 24, caracterizada porque dicho agente lubricante comprende polivinil pirrolidona. Reivindicacion 28: La composicion de la reivindicacion 27, caracterizada porque dicho al menos un potenciador de la desinfeccion se selecciona del grupo formado por polioles C5-20.
ARP090100992A 2008-03-19 2009-03-19 Soluciones oftalmicas que muestran una eficacia mejorada AR070999A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3789408P 2008-03-19 2008-03-19
US12/399,662 US20090239775A1 (en) 2008-03-19 2009-03-06 Ophthalmic solutions displaying improved efficacy

Publications (1)

Publication Number Publication Date
AR070999A1 true AR070999A1 (es) 2010-05-19

Family

ID=41089519

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090100992A AR070999A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas que muestran una eficacia mejorada
ARP090100994A AR071001A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP090100994A AR071001A1 (es) 2008-03-19 2009-03-19 Soluciones oftalmicas bufferizadas con fosfato que exhiben eficacia mejorada

Country Status (12)

Country Link
US (2) US20090239775A1 (es)
EP (2) EP2271313A1 (es)
JP (2) JP2011515394A (es)
KR (2) KR20100135813A (es)
CN (2) CN101977590A (es)
AR (2) AR070999A1 (es)
AU (2) AU2009226112A1 (es)
BR (2) BRPI0909000A2 (es)
CA (2) CA2718864A1 (es)
RU (2) RU2010142488A (es)
TW (2) TW201000149A (es)
WO (2) WO2009117056A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100226999A1 (en) * 2009-03-06 2010-09-09 Tracy Quevillon-Coleman Process for forming stabilized ophthalmic solutions
WO2011001461A1 (ja) 2009-06-29 2011-01-06 株式会社メニコン コンタクトレンズの消毒システム
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
JP2011251932A (ja) * 2010-06-01 2011-12-15 Mandom Corp 点眼剤及び洗眼剤
JP5345745B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物
WO2014153733A1 (en) * 2013-03-27 2014-10-02 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
WO2014190141A1 (en) * 2013-05-23 2014-11-27 Stone Ralph P Scleral lens solution
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
EP3784354A1 (en) 2018-04-27 2021-03-03 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
CN114318343A (zh) * 2020-09-29 2022-04-12 上海飞凯材料科技股份有限公司 一种蚀刻液及其应用
TW202430231A (zh) * 2022-12-21 2024-08-01 美商壯生和壯生視覺關懷公司 眼用裝置之組成物
WO2024134381A1 (en) * 2022-12-21 2024-06-27 Johnson & Johnson Vision Care, Inc. Compositions for ophthalmologic devices
TW202434214A (zh) * 2022-12-21 2024-09-01 美商壯生和壯生視覺關懷公司 眼科裝置之組成物(二)

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
US5277901A (en) * 1990-01-05 1994-01-11 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5451398A (en) * 1990-01-05 1995-09-19 Allergan, Inc. Ophthalmic and disinfecting compositions and methods for preserving and using same
US5145643A (en) * 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5171526A (en) * 1990-01-05 1992-12-15 Allergan, Inc. Ophthalmic compositions and methods for preserving and using same
US5019380A (en) * 1990-04-27 1991-05-28 Bausch & Lomb Incorporated Novel antimicrobial compositions and process for preparing the same
US5523012A (en) * 1991-07-19 1996-06-04 Ciba-Geigy Corporation Hydrogen peroxide disinfection solutions
DE4132259A1 (de) * 1991-09-27 1993-04-01 Wild Heerbrugg Ag Ueberstrahlungsschutz fuer ein nachtsichtgeraet
US5356555A (en) * 1992-09-14 1994-10-18 Allergan, Inc. Non-oxidative method and composition for simultaneously cleaning and disinfecting contact lenses using a protease with a disinfectant
EP0674532B1 (en) * 1992-12-17 2003-05-28 Advanced Medical Optics, Inc. Contact lens disinfecting solution containing an oxidizing agent and polyvinyl pyrrolidone
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
US5648074A (en) * 1993-05-25 1997-07-15 Allergan Compositions and methods for disinfecting contact lenses and reducing proteinaceous deposit formation
JP2839819B2 (ja) * 1993-05-28 1998-12-16 株式会社東芝 不揮発性半導体記憶装置
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
FR2751634B1 (fr) * 1996-07-29 1998-09-11 Essilor Int Solution stabilisee et tamponnee de peroxyde d'hydrogene, son procede de fabrication et son utilisation a la decontamination de lentilles de contact
US5746972A (en) * 1996-11-01 1998-05-05 Allergan Compositions and methods for disinfecting and cleaning contact lenses
AU6416999A (en) * 1998-10-08 2000-04-26 Hampar L. Karagoezian Synergistic antimicrobial, dermatological and ophthalmic preparations containingchlorite and hydrogen peroxide
AU1458300A (en) * 1998-10-30 2000-05-22 Metrex Research Corporation Simultaneous cleaning and decontaminating compositions and methods
US6309596B1 (en) * 1998-12-15 2001-10-30 Bausch & Lomb Incorporated Treatment of contact lenses with aqueous solution comprising a biguanide disinfectant stabilized by a poloxamine
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20070104798A1 (en) * 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
WO2002026277A2 (en) * 2000-09-28 2002-04-04 Novartis Ag Stabilized hydrogen peroxide solutions
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20050244509A1 (en) * 2004-03-17 2005-11-03 Fu-Pao Tsao Ophthalmic solutions
CN101420934B (zh) * 2006-03-17 2014-03-19 庄臣及庄臣视力保护公司 用于使氧化不稳定的组合物稳定的方法
US20090004288A1 (en) * 2007-06-29 2009-01-01 Collins Gary L Stabilized ophthalmic solutions

Also Published As

Publication number Publication date
WO2009117056A1 (en) 2009-09-24
EP2276462A1 (en) 2011-01-26
CN101977591A (zh) 2011-02-16
RU2010142462A (ru) 2012-04-27
CA2718864A1 (en) 2009-09-24
JP2011515393A (ja) 2011-05-19
CN101977590A (zh) 2011-02-16
BRPI0909763A2 (pt) 2015-10-06
CA2718866A1 (en) 2009-09-24
US20090239775A1 (en) 2009-09-24
AU2009226113A1 (en) 2009-09-24
US20090239954A1 (en) 2009-09-24
AU2009226112A1 (en) 2009-09-24
BRPI0909000A2 (pt) 2015-08-04
TW201000149A (en) 2010-01-01
TW200950822A (en) 2009-12-16
KR20100135813A (ko) 2010-12-27
KR20100126512A (ko) 2010-12-01
RU2010142488A (ru) 2012-04-27
EP2271313A1 (en) 2011-01-12
WO2009117057A1 (en) 2009-09-24
JP2011515394A (ja) 2011-05-19
AR071001A1 (es) 2010-05-19

Similar Documents

Publication Publication Date Title
AR070999A1 (es) Soluciones oftalmicas que muestran una eficacia mejorada
Agrawal Vineet et al. A contemporary overview of endodontic irrigants–A review
ATE402712T1 (de) Synergistische antimikrobielle ophthalmische zubereitungen mit chlorit- und wasserstoffperoxid
AR055679A1 (es) Sistema y metodo para la prevencion de infecciones bacterianas y fungicas que incluyen a las infecciones del tracto urinario (itu) utilizando aminoacidos n- halogenados
DE3569836D1 (en) Disinfecting method and compositions
GB0219569D0 (en) Improvements in or relating to organic compositions
PT96432A (pt) Processo de desinfeccao de lentes de contacto num meio liquido como dioxido de cloro ou um seu precursor
JPH0622543B2 (ja) コンタクトレンズ消毒系
CA2003549A1 (en) Hypochlorite compositions containing thiosulfate and use thereof
DE60104872D1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung
EP3223611B1 (en) Two components disinfecting composition containing peracetic acid and chelating agent
NZ523490A (en) Two-part antimicrobial composition useful for the treatment of bovine mastitis
AR076932A1 (es) Formulaciones de n-halamina con actividad antimicrobiana aumentada. comprimido desinfectante. metodo para desinfectar.
JP2005177515A (ja) 多価陽イオンキレート剤を用いて、アイケア用品における原生動物の増殖を抑制する方法
AR095681A2 (es) Una solución acuosa desinfectante no terapéutica, un método para prepararla, una preparación desinfectante y un método para desinfectar o esterilizar un objeto
CO5580725A2 (es) Herbicidas selectivos a base de tien-3-ilsulfonilamino (tio)-carbonil-triazolin(tio)onas substituidas y protectores
RU2017104882A (ru) Композиция жидкости для полоскания полости рта, содержащая источник пероксида и соль алкилового эфира n-ацил-l-аргинина
CA2569025C (en) Powdered composition for the generation of peracetic acid and use thereof to sanitize surfaces
WO2001087358A1 (en) Method of removing microbial contamination
JP6057526B2 (ja) 開放循環冷却水系の処理方法
US6103189A (en) Method of removing microbial contamination
RU2010102904A (ru) Стабилизированные офтальмические растворы
PE20030729A1 (es) Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas
ES2230040T3 (es) Desinfeccion de endoscopios con una solucion acuosa de acido paracetico y de peroxido de hidrogeno.
BR9811706A (pt) Composições antimicrobianas brandas sem-remoção

Legal Events

Date Code Title Description
FB Suspension of granting procedure